TORONTO, ONTARIO–(Marketwire – Aug. 24, 2010) – Proponents of for-profit private health care claim our public health care system is “unsustainable,” but the facts show that these claims are driven far more by ideology than real data. Canadian Doctors for Medicare’s briefing note, Health Care Sustainability, explains the issues underlying the debate about health care sustainability, and how physicians in Canada can work together to control health care costs and to improve our health care system for the benefit of all Canadians.

Canadian Doctors for Medicare (CDM) is a national, membership-based organization that believes in Canada’s publicly-funded health care system. The organization’s mission is to provide a voice for Canadian doctors who want to strengthen and improve Canada’s universal publicly-funded health care system in a way that benefits all Canadians. 

TUSTIN, CA–(Marketwire – August 24, 2010) –  Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced today broad availability of its 2010 Onko-Sure® Reference Guide for the Company’s USFDA-approved Onko-Sure® in vitro diagnostic (IVD) cancer test kit.

The 2010 Onko-Sure® Reference Guide is a commercially published compilation of Radient Pharmaceuticals general information and clinical studies on the Company’s Onko-Sure® IVD cancer test kit. Designed to provide oncologists, physicians and clinicians with the most current and important information for Onko-Sure®, the guide also serves as a comprehensive reference for other health care professionals, consumers and patients.

In addition to general Company information and Onko-Sure® clinical study data, RPC’s 2010 Onko-Sure® Reference Guide provides a comprehensive list of key references, resources and other published materials users can consult to better understand the medical utilities of Onko-Sure®, how healthcare providers and patients can use the test and the science behind Onko-Sure®. 

RPC’s Onko-Sure® IVD cancer test is a simple, non-invasive, patent-pending and regulatory-approved in vitro diagnostic (IVD) test used for the detection, screening, and monitoring of various types of cancer. The test enables physicians and healthcare professionals to effectively monitor and/or detect certain types of cancers by measuring the accumulation of Fibrin and Fibrinogen Degradation Products (FDP) in the blood. FDP levels rise dramatically with the progression of cancer. Onko-Sure® is approved by the US FDA for the monitoring of colorectal cancer and by Health Canada as a lung cancer detection and monitoring test. 

According to Mr. Douglas MacLellan, Chairman and CEO of Radient Pharmaceuticals, “The 2010 Onko-Sure® Reference Guide is an invaluable resource for both members of the healthcare community and patients alike, and we believe it will serve as an important educational tool that will drive broad-based adoption and use of RPC’s Onko-Sure® IVD cancer test for the diagnosis, treatment and monitoring of cancer.”

RPC’s 2010 Onko-Sure® Reference Guide is available in both print and on-line versions. Print versions can be ordered by contacting Radient Pharmaceuticals at 1-714-505-4461 or via e-mail [email protected]; and online versions are available for download by visiting the Radient Pharmaceuticals corporate website at www.Radient-Pharma.com or RPC’s Onko-Sure®-dedicated website located at www.onko-sure.com.

RPC Contact Information:
For additional information on Radient Pharmaceuticals, ADI and its portfolio of products visit the Company’s corporate website at www.Radient-Pharma.com. For information specifically related to Onko-Sure® visit www.onko-sure.com. For Investor Relations information contact Kristine Szarkowitz at [email protected] or 1.206.310.5323.

About Radient Pharmaceuticals:
Headquartered in Tustin, California, Radient Pharmaceuticals is dedicated to saving lives and money for patients and global healthcare systems through the deployment of our Onko-Sure™ In Vitro Diagnostic cancer test. Our focus is on the discovery, development and commercialization of unique high-value diagnostic tests that help physicians answer important clinical questions related to early disease detection; treatment strategy; and the monitoring of disease progression, prognosis, and diagnosis to ultimately improve outcomes for patients. Radient Pharmaceutical’s current Onko-Sure™ cancer test is used to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, perform additional testing, or assist in the selection of therapy. To learn more about our company, people and potentially life-saving cancer test, visit www.radient-pharma.com. 

Forward-Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

Click here to see all recent news from this company

HOUSTON, TX–(Marketwire – August 24, 2010) –  Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas-based, diversified medical services provider, discusses recent events in detail below.

The company released its June 30, 2010 quarterly financials. As mentioned in the Management Discussion part of the filings, the financials of its recent acquisition, Texas Mobile Health (TMH), were included. The company has not been able to achieve the level of sales it had anticipated due to the overall unemployment situation causing loss of insurance benefits and therefore lower patient visits to doctors. Also, the recently passed Healthcare Legislation has caused many physicians, particularly in Texas, to opt out of Medicare therefore causing TMH to lose several doctor clients. In addition to all of this, Medicare has cut back reimbursements by 30-40%.

TMH is exploring other areas of diagnostic testing services to increase sales and these areas will be discussed in future releases.

The company reported that it had received a subpoena from the SEC. The subpoena requests certain information concerning the recently reported short selling activities in the company’s common stock and historical stock issuances. Management is fully cooperating with the Commission and will provide it information that management has compiled including weekly DTC Securities Positions Reports, its most recent NOBO list, registered shareholder list, reports and information from Buyins.net and spreadsheets prepared by management together with records requested of the company’s former transfer agent. Management also reiterated that it intends to maintain its Pink Sheets Current Information status as the company’s minimum level of transparency and disclosure as it continues to grow its business internally and through acquisitions.

As previously stated, the company’s long-term goal is to become a fully reporting company and has begun this process by achieving Pink Sheet Current Status.

About Bederra Corp.
http://www.bederra.com
Bederra Corporation provides multiple modality diagnostic medical imaging services to the greater Houston area and the world famous Texas Medical Center. The Company’s business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectations.

LOS ANGELES, CA–(Marketwire – August 24, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrglobal.com) through its subsidiary, MyMedicalRecords, Inc. (www.mymedicalrecords.com), a leading provider of Personal Health Records (PHR) technology and professional document management and imaging systems, today announced the signing of a distribution agreement with Image Access Corporation, Kodak’s largest reseller of document imaging products and services. Image Access, in business for over 20 years, will sell the MMRPro electronic document management solution to hospitals, alternate care facilities and physician practices and clinics (www.mmrprovideos.com).

Robert H. Lorsch, Chairman and CEO of MMRGlobal, commented, “We are excited about Image Access joining our growing list of resellers in support of the deployment of MMRPro. Image Access through its offering of MMRPro enables its customers to take the first step toward meaningful use.”

MMRGlobal also recently announced its move to new corporate headquarters, expanding its office space by more than 300%. The offices are located in the Associated Television International building (www.associatedtelevision.com), the Company’s strategic media and advertising partner, at 4401 Wilshire Blvd. 2nd Floor, Los Angeles, California 90010. The move will enable MMRGlobal to house development resources from its technology partner, Nihilent in India. The two companies are working together in support of MMRGlobal’s worldwide expansion of its products and services, including China.

About MMRGlobal, Inc.

MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of these words. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation and initiatives, uncertainties associated with doing business internationally across borders and territories, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

Click here to see all recent news from this company

MADISON, WI–(Marketwire – August 24, 2010) –  TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced, integrated radiation therapy solutions for cancer care, announced today that General Hospital of Guangzhou Military Command of PLA has purchased the first TomoTherapy^® radiation therapy system to be installed in Southern China. The TomoTherapy treatment system will enable the hospital to provide advanced cancer care to a wide variety of patients, including those with head and neck cancers.

“In this area of Southern China, we see a large number of patients who suffer from head and neck cancers. But our aging linear accelerator technology has limited our ability to treat these patients, forcing us to refer them to other cancer centers,” said Jian Liu, president of PLA Guangzhou Hospital, which treats more than 1 million patients annually. “The TomoTherapy platform will enable us to expand our care and deliver treatments for the most complicated cases very effectively and accurately with its integrated daily 3-D imaging.”

The TomoTherapy radiation therapy system allows clinicians to provide helical image-guided, intensity-modulated radiation therapy (IG-IMRT), which has been shown to offer better dosimetric distributions when compared to traditional IMRT treatments. PLA Guangzhou will use the TomoTherapy treatment system to address complex nasopharyngeal cancer cases, in which patients can suffer significant side effects. The daily megavoltage CT (MVCT) imaging offered by the TomoTherapy treatment system will allow clinicians at PLA Guangzhou General Hospital to better monitor changes to the parotid glands, and calculate the dosage they receive. In addition, the TomoTherapy system’s innovative adaptive planning capabilities enable clinicians to quickly and easily re-plan treatment so that the dosage received is optimized over the course of treatment.

“With its plan to focus its TomoTherapy treatments on complex head and neck cancers, we believe that PLA Guangzhou General Hospital will quickly become one of the premier locations for these types of treatments in Southern China,” said Fred Robertson, CEO of TomoTherapy. “We are happy to continue our strong relationship with our distributor TomoKnife to expand access to TomoTherapy technology for the benefit of clinicians and patients throughout China.”

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy^® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art^® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD^™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile^™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

Forward-Looking Statements
Statements in this release regarding future products or product capabilities, events, expectations and other similar matters, including but not limited to statements using the terms “may,” “should,” “suggests” or “indicates” constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including but not limited to factors such as our ability to integrate acquired assets, ability to protect intellectual property, risks of interruption due to events beyond the company’s control, and the other risks listed from time to time in TomoTherapy’s filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. These forward-looking statements represent TomoTherapy’s judgments as of the date of this press release. TomoTherapy assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events or otherwise.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

DALLAS, TX–(Marketwire – August 24, 2010) –  Too many men have suffered in silence for too long, according to Dr. Bill Johnson, Medical Director of Innovations Medical. He wants more men to “Loose the Moobs” by leveraging modern cosmetic procedures to solve a serious problem.

Male breast fat.

“Either more men are developing flabby pecs, or men are just taking better care of themselves now,” says Dr. Johnson. “We’ve seen the interest in male breast fat reduction jump dramatically in the last year.”

Johnson’s team of technicians at Innovations medical has seen a 300% increase in the demand for this procedure over the last 3 years. “These days, I see at least one ‘moob’ patient per week,” says Johnson. “All of them want liposuction to reduce their chest fat.”

Medically, it’s called gynecomastia, but most men refer to their enlarged breasts as “moobs.” Some Hollywood glitterati have been snapped with “moobs”: Jack Nicholson, Tom Cruise, even Arnold Schwarzenegger. There are numerous YouTube videos. But no one needs to put up with it, according to Johnson.

Causes can include obesity, hormones and kidney disease, but most of the determining factors are genetic.

“A decade ago, men didn’t seek out cosmetic procedures to address their appearance, but they do now,” says Dr. Johnson. “It’s simple and effective.” Dr. Johnson’s unique “moob” liposuction takes less than one hour, and the patient is awake the entire time. “A guy can come in, have the procedure, and be back at work the next day,” says Johnson. He combines two popular lipo technologies — Tickle Liposuction and SmartLipo. The combination allows for removal of excess fat and skin tightening in the chest area.

“I want more men to take better care of themselves,” says Dr. Johnson. “Get over the hesitation and loose the moobs!”

Innovations Medical is a full-service aesthetic medical practice with locations in Dallas, Fort Worth and Grapevine, Texas. Medical Director Bill Johnson, M.D., has been treating patients in North Texas since 1984. As the name implies, Innovations Medical was the first in North Texas to offer many leading-edge technologies, including SmartLipo, Vibro Liposuction and Acoustic Wave Therapy for cellulite. www.innovationsmedical.com

Click here to see all recent news from this company

LOUISVILLE, KY–(Marketwire – August 24, 2010) –  ZirMed®, a leading national provider of revenue cycle management solutions for healthcare providers, today announced the addition of a first-of-its-kind new self-sign up capability for Patient Notebook, ZirMed’s online electronic billing and patient medical account management solution. The self-sign up function allows patients to enroll themselves to receive and pay their medical bills electronically for multiple healthcare providers in a single convenient, secure location.

With the new self-sign up feature, patients not only enjoy the convenience and privacy of enrolling for the service from the comfort of their own home, but healthcare practices also benefit from the improved workflow, reduced paperwork and cost savings of having more patients enroll in electronic bill presentment.

“Self-subscription had been a major hurdle due to HIPAA regulations and logistical concerns, but we’ve been able to overcome these challenges to offer a new level of convenience and efficiency to both the provider and the patient,” said Jim Lacy, ZirMed CFO. “As healthcare evolves into a more consumer-driven industry, this new feature demonstrates our view of giving patients more transparency into the payment process. Our approach is a fundamental step in giving patients control over their healthcare information, both financial and clinical.”

The new self-enrollment feature allows patients to sign up online to receive billing statements and pay bills at www.patientnotebook.com. Prior to this capability, office staff had to ask patients to sign up and enroll at the office. With the self-sign up feature, the office has the flexibility to continue to enroll patients or direct them to Patient Notebook to sign themselves up for this service.

For more information about Patient Notebook visit www.zirmed.com or www.patientnotebook.com.

About ZirMed:
Founded in 1999, ZirMed is a nationally recognized leader in delivering revenue cycle management solutions to healthcare providers. ZirMed enables healthcare providers to leverage the power of technology to cure administrative burdens and increase cash flow. ZirMed solutions include eligibility verification, credit/debit card processing, check processing, claims management, coding compliancy and reimbursement management, electronic remittance advice, patient statements, patient e-commerce solutions, provider credentialing, and lock box services. ZirMed solutions are designed to complement provider workflow and to provide innovative, creative and flexible solutions for healthcare’s most pressing administrative challenges. For more information about ZirMed, visit www.zirmed.com/pr. 

PLANTATION, FL–(Marketwire – August 24, 2010) –  Transax International Limited (Transax) (OTCQB: TNSX), a network solutions company for healthcare providers and health insurance companies, today reported financial results for the first half of 2010 and second quarter ended June 30, 2010.

For the quarter ending June 30, 2010 Transax generated net revenues of $1,046,429 compared to $1,093,705 in net revenues during second quarter of 2009, a 4% decrease. The decrease in revenue is due to the loss of one minor contract during the second quarter 2010 partly offset by continued growth in real-time transactions and rollout of previously announced contracts. Transaction volume was 2.3 million for the second quarter of 2010 compared to 2.1 million in the same period during 2009.

Loss from operations in the second quarter of 2010 was $418,904 compared with a $243,988 loss during the same period in 2009. Net loss for the second quarter of 2010 was $975,480 compared with a net loss in the second quarter of 2009 of $3,442,588. The decrease in net loss is principally due to a decrease in non cash items related to derivative liabilities expenses.

For the quarter ending June 30, 2010, the Company incurred $1,465,333 in operating expenses compared to $1,337,693 during the same period in 2009. The increase in expenses was attributed to significant increases in cost of product support services together with general and administrative expense increases in complying the Company products to new government regulations in Brazil.

For the six months ended June 30, 2010 revenues increased by 1% to $2,069,261 from $2,046,023 during the same period in 2009. The loss of one customer during the period was partially offset by revenues from new customers during the period. The Company recorded an operational loss of $938,180 for the six months ending June 30, 2010 compared to operational loss of $561,171 for the six months ending June 30, 2009. Net loss for the first six months of 2010 was $1,367,493 compared to a net loss of $3,721,815 for the same period in 2009.

At the end of the second quarter 2009 the Company had over 20,150 solutions installed in Brazil including 3,125 Point of Sales (POS) Solutions, 16,350 operational WEB solutions and 1,870 Interactive Voice Response (IVR) solutions with the balance of PC and Server solutions installed in medical laboratories. During the six month period ending June 30, 2010 the company installed over 5,000 WEB solutions to medical provider locations to support future roll out and revenue growth.

In announcing the results Stephen Walters, President & CEO, stated, “Transaction volumes have increased steadily during 2010 recording a 11% annual increase. The company installed 1,250 solutions during July 2010 and recorded over 850,000 for the month of July 2010. Additional roll out of solutions to increase revenues and reduction in operating costs is the main target of the company for the second half of the year.”

About Transax International Limited

Transax International is an emerging network solutions provider for the healthcare sector. Utilizing its proprietary MedLink™ technology, Transax provides a service similar to credit card processing for the health insurance and providers industries. A transaction consists of: approving eligibility, authorization, auto-adjudication of the health claim and generating the claim payable files — provided instantaneously in “real time” — regardless of method of claim generation.

Transax’s solutions have been proven to significantly decrease health insurance claim expenditures and healthcare provider costs. Based in Plantation, Fl, Transax maintains a major operations office in Rio de Janeiro, Brazil, with approximately 45 staff and a Sales Office in Sao Paulo, Brazil. The Company has contracts in place with major health insurers in Brazil and currently undertakes approximately 800,000 transactions per month.

SAFE HARBOR STATEMENT: “THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, THE COMPANY’S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE ‘SAFE HARBOR’ PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.”

MELVILLE, NY–(Marketwire – August 24, 2010) – FONAR Corporation (NASDAQ: FONR), the Inventor of MR Scanning™, announced the purchase of an UPRIGHT® Multi-Position™ MRI by a distinguished Board Certified radiologist in Florida. He is the owner operator of two multi-modality imaging centers equipped with MRIs.

“He was initially considering purchasing a 3 Tesla lie-down MRI,” said Raymond V. Damadian, M.D., president and founder of FONAR Corporation, “but decided instead to buy the FONAR UPRIGHT® Multi-Position™ MRI when he became aware of its many unique imaging capabilities.”

As he explained, “many of the physicians who send patients to our multi-modality medical imaging practices are surgeons who perform spine surgery. It is a very important specialty in medical practice since the second most common reason today, after the common cold, for visiting a doctor’s office is ‘back pain.’

“Each year, 40 to 60 percent of American adults suffer from chronic back pain. More than one million spine surgery procedures are performed annually, with medical costs to treat back pain approaching $24 billion per year. (http://nyp.org/news/hospital/spine-fusion-surgery.html).

“As of 2007, approximately 9 million of the 27.5 million MRIs performed each year in the U.S. are of the spine.

“Accordingly,” he said, “aware that the number one priority of all my referring spine surgeons is the best possible outcomes for their patients, I became convinced that the only technology capable of maximizing the surgical outcomes for my physician senders was to assure that they were able to see ALL of the pathology they had to address, not just part of it from a lie-down scanner in which the body weight has been removed.”

“The spine is a difficult region of anatomy for the surgeon,” he continued, “because as the principal weight-bearing structure of the body it shows its wear and tear degeneration early on. Consequently, degenerative changes of the spine are a normal concomitant of the aging process. This reality, however, from the surgeon’s perspective, can be confounding. Does he, for example, surgically address the degenerative loss of disc height and neural foramina narrowing at L1/2, the ‘spondy’ at L2/3, or the disc herniation at L4/5? It is evident that if a vertebral segment not responsible for the patient’s pain is subjected to surgery, the pain will not improve and there is even the risk that the patient’s clinical condition and pain could be made worse by carrying out surgery on the wrong segment.”

“Consequently,” he stated, “the key to a good surgical outcome is the success with which the degenerative changes responsible for the patient’s pain, are successfully separated from the degenerative changes that are not causing the patient’s pain, so that only those segments responsible for the patient’s pain are operated on.”

“Of all the commercially available MRI scanners,” he said, “the FONAR UPRIGHT® Multi-Position™ scanner is the only MRI that meets this need. What FONAR’s UPRIGHT® Multi-Position™ weight-bearing technology makes possible that no other scanner can accomplish is the ability for the radiologist to ask the patient to put himself in the position (standing, sitting, lateral bending, flexion, extension, rotation, etc.) that generates his pain, which no other scanner can do. A picture can then be taken with the patient in his actual pain generating position and then compared to a picture of the patient in an adjacent non-pain-generating position so that the correct pain generating anatomy can be unequivocally identified. This permits the surgeon to address only the anatomy segment generating the patient’s pain, and enables him to avoid surgery on segments not involved in pain generation. The ultimate result is excellent outcomes for the surgeons and their patients.

“A recumbent non-weight-bearing single-position MRI simply cannot meet this need. We see it as a critical need, if we are going to be successful in improving surgical outcomes for our patients.

“Also important to our surgeons is their ability to see their surgical results post-operatively, which the FONAR UPRIGHT® Multi-Position™ MRI can accomplish and the conventional MRI cannot. In the event of a less than optimal surgical outcome, or even an outcome that deteriorates over time, it is critical for the surgeon to be able to see post-operatively any hardware devices he may have implanted (e.g. artificial discs, pedicle screws, fusion rods, etc.) in order to address any surgical results that require further attention. Consequently, being able to clearly visualize installed implants in the post-operative spine is key for the surgeon to be able to address any further needs the patient might have.

“The FONAR scanner at 0.6 T meets this need of the surgeon since it is uniquely spared the magnetic susceptibility image artifacts that the 1.5 T and 3.0 T lie-down scanners generate. The implant artifacts obliterate the anatomy of the vertebral segments that are being imaged and make it impossible for the surgeon to discern the source of any persisting post-operative symptoms or pain that the patient might be experiencing.”

He also expressed the need to be able to provide the unique imaging capabilities provided by the FONAR UPRIGHT® scanner to distinguish his radiology practice from competing radiology centers. “The FONAR UPRIGHT® Multi-Position™ MRI is the quintessence of the technology for breaking existing referral patterns. By offering the unique capabilities of the FONAR UPRIGHT® MRI,” he stated, “and thereby distinguishing our radiology practice from competitors who market the same ‘me-too’ products, we would be bringing to our community a ‘Center of Excellence’ for imaging the spine. In so doing, we would be establishing for our community a COMPLETE radiology imaging service that could not be obtained elsewhere. Ultimately this would generate business for all of our imaging modalities. By offering a COMPLETE imaging service that includes all of FONAR’s new UPRIGHT® imaging technologies that are not available anywhere in our community, we would achieve ‘One Stop Shopping’ for our patients to address all of their imaging needs.”

“An example of one of the many unique imaging capabilities made possible by the FONAR UPRIGHT® Multi-Position™ fully weight-loaded imaging,” he continued, “is the ability to image, without x-ray, the 400,000 scoliosis patients that must be imaged UPRIGHT® 2 to 3 times per year to monitor their scoliosis treatment. The elimination of x-ray avoids the 70% increased incidence of breast cancer reported by the National Cancer Institute to be the result of the standard annual x-ray examinations of these patients (National Cancer Institute, www.cancer.gov and M. Morin Doody et al. Spine, 8/15/2000, Vol. 25, #16).

“Another example is the ability to scan small children and infants seated on their mother’s lap as they watch their favorite cartoon on the flat screen TV shipped with the system. This greatly reduces the number of children requiring anesthesia when MRI is needed and is a valuable feature of the FONAR UPRIGHT® that we will be bringing to our pediatric community.

“In addition, the ability to scan UPRIGHT® the large population of women suffering from the PFD (pelvic floor dysfunction) symptoms of cystitis, urinary incontinence and bowel dysfunction is another valuable benefit of the UPRIGHT® MRI. Because of the FONAR UPRIGHT® MRI, the cause of these dysfunctions can now be definitively shown on the MRI images and successfully treated surgically. These pelvic floor dysfunctions are the result of the cystic, vaginal, and rectal prolapses generated by the pelvic floor stresses of childbirth. They are readily visualized,” he said, “by the FONAR UPRIGHT® MRI but are not readily diagnosed by the gynecologist employing the conventional lie-down pelvic examination.”

“There are also now,” he stated, “a large number of patients suffering the consequences of automobile whiplash injuries (Brain Injury, July 2010; 24[7-8]:988) and the ‘fallen’ cerebellar tonsil syndrome (Chiari or CTE; cerebellar tonsil ectopia) that results. The ‘fallen’ cerebellar tonsils require UPRIGHT® imaging to be seen and cannot satisfactorily be visualized by a conventional lie-down MRI. It is another unique need met by the FONAR UPRIGHT® MRI capability.”

“In addition, there is now the power using FONAR’s new cerebro-spinal fluid (CSF) flow technology,” he said, “to create cinés of cerebro-spinal fluid flow, and in particular, to be able to create cinés of this CSF flow in the upright position so that the adequacy of CSF flow into the upright brain can be quantified and visualized. Imaging patients in the upright position assures there are no dynamic impairments to this vital cerebro-spinal function and enables their correction if it exists. With the recent increased incidence of automobile whiplash injuries (C.S.B. Galasko et al., J. Musc-Skel. Pain 2000, Vol. 8, No. 1-2, p. 15) and the cerebellar tonsillar ectopias (CTE) that result, it is critical to identify this pathology as soon as it occurs so it can be addressed before more dire consequences occur.”

“The ‘Thoracic Outlet Syndrome (TOS)’ is yet another symptom complex,” he further stated, “that can benefit from FONAR’s UPRIGHT® imaging technology. The ‘TOS’ patients can now be scanned upright in the FONAR UPRIGHT® Multi-Position™ MRI and placed in the positions that compress the brachial plexus and subclavian artery so that the pathologic anatomy causing the compressions can be visualized and specifically addressed surgically when necessary.

“There is also now the newly recognized Pelvic Congestion Syndrome (PCS) that needs the benefits of UPRIGHT® imaging. PCS is a symptom complex in women where pelvic pain arises secondary to venous congestion and pelvic varicosities. Prolonged standing, in particular, gives rise to the pain and has to be diagnostically distinguished from other causes of pelvic pain such as fibrosis and endometriosis. Placing the patient upright in the FONAR UPRIGHT® Multi-Position™ MRI can readily visualize the pain generating venous congestion and pelvic varicosities so that a definitive diagnosis can be achieved and treatment administered.

“Another valued application for the FONAR UPRIGHT® Multi-Position™ MRI scanner is its potential for evaluating the ‘runner’s knee’ syndrome, i.e. the Patella Femoral Pain Syndrome (PFPS). In the light of the current day practice of daily running exercise to achieve aerobic fitness, accurate diagnosis of the fully weight-loaded ‘runner’s knee’ in different degrees of flexion and extension, including single leg squats, is a growing need. The FONAR UPRIGHT® Multi-Position™ MRI makes possible the visualization of the cartilage contact surfaces of the knee, namely, the miniscal and articular cartilage surfaces that support the body’s weight and enable smooth motion of this dynamic weight-supporting structure. This enables the risks from any long-bone malalignments or patella tracking dysfunctions that give rise to ‘runner’s knee’ to be assessed and addressed before they result in a permanent debilitating osteoarthritis. University biomechanical specialists have recently been conducting research using the FONAR UPRIGHT® Multi-Position™ MRI to explore and better define the ‘runner’s knee’ condition and the ‘patellar tracking’ abnormalities that can aggravate it. The FONAR UPRIGHT® cinés of the fully weight-bearing knee make the multi-position dynamic visualization of ‘runner’s knee’ and the diagnostic analysis of it a reality.

“Particularly valuable to me as a radiologist,” he continued, “is FONAR’s new Correlated Slice Profile (CSP) technology. It takes the FONAR Multi-Position™ MRI technology to a new level. With FONAR’s Correlated Slice Profile (CSP) technology, each slice of a 15-slice multi-slice MRI scan of the spine appears on the radiologist’s screen (or film) adjacent to the images of the other positions of the same slice. By re-centering the slices prior to the image acquisition of a new position, the slices of each position scan remain correlated despite any shifts of the body axis that result from changes in body position. The radiologist can then view each slice of the scan in all 3 of its weight-bearing positions, neutral sit, flexion and extension, alongside the same slice from the recumbent position. This enables the radiologist to easily track a given pathology (e.g. a disc herniation or spondylolisthesis) through all of its four positions so the surgeon can be advised of the full range the patient’s spinal pathology (e.g. disc herniation, spondylolisthesis) traverses during the daily range of his/her body positions. By so doing, the surgeon sees the FULL EXTENT of the pathology he must address to get a good outcome.

“I agree with FONAR’s German customer who just ordered their 4^th FONAR UPRIGHT® MRI because of their business success with FONAR’s new technology (Press Release, FONAR Corporation, August 3, 2010). We agree with them that FONAR’s UPRIGHT® Multi-Position™ MRI is indeed setting a new MRI ‘standard of care’ for a wide range of medical applications.”

For investor and other information visit: www.fonar.com.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, pMRI™, Dynamic™, Multi-Position™, True Flow™, The Proof is in the Picture™, Spondylography™ Spondylometry™ and Upright Radiology™ are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company’s financial results may be found in the company’s filings with the Securities and Exchange Commission.

CLARK, NJ–(Marketwire – August 24, 2010) –  HealthEd, a specialized agency focused on turning health education into positive outcomes, today announced the appointment of Raffaele Piemonte as chief technology officer (CTO). With the addition of Piemonte to the company’s executive team, HealthEd aims to position itself for further growth in this year’s fourth quarter and in 2011.

“We’re committed to improving people’s lives and helping our clients find new and engaging ways to do that,” said Roy Broadfoot, CEO and president of HealthEd. “Digital solutions will be critical to achieving that goal. Raffaele’s extensive experience in developing original applications, combined with his deep understanding of the integration of IT, business, and operational needs, perfectly aligns with the company’s mission of creating a healthier world.”

As CTO, Piemonte will be responsible for developing and executing HealthEd’s technology strategy and leading its technology team. Mr. Piemonte brings to the growing company a variety of IT expertise in several areas, including software architecture, identity management, project life cycle management, and business process optimization. Piemonte’s appointment signals the company’s commitment to making digital marketing integral to its growth and development.

Previously, Mr. Piemonte was with KPMG as director of application integration services. His prior experience includes CTO positions with IEG-Sponsordirect, Riverblade, and Ingredients.com.

Mr. Piemonte’s experience also includes presenting at numerous conferences and penning several articles for various tech journals as well as coauthoring “Developing Applications Using Outlook 2000, CDO, Exchange and Visual Basic,” a comprehensive reference guide for IT professionals for building program applications in collaboration with Microsoft platforms and tools.

About HealthEd
HealthEd is a specialized agency that uses education to help people develop the knowledge, skills, motivation, and confidence to manage important health decisions and activities and ultimately achieve better health outcomes. For more information about HealthEd and the services we offer, please visit http://www.HealthEd.com or contact Anita St. Clair, chief client development officer, at 908-389-2133.

Click here to see all recent news from this company

NIAGARA FALLS, ONTARIO–(Marketwire – Aug. 22, 2010) – Canadian doctors have applauded the Canadian Medical Association’s affirmation of the principle of universal access to health care regardless of ability to pay, but urge the CMA to ensure that future reform proposals are firmly based on the principle of equity. Canadian Doctors for Medicare’s assessment of the CMA’s Health Care Transformation policy document examines some of the CMA’s main proposals and offers some suggestions to Canadian physicians about how they can work together to help reform the health care system so that reforms benefit all Canadians.

Canadian Doctors for Medicare (CDM) is a national, membership-based organization that believes in Canada’s publicly-funded health care system. The organization’s mission is to provide a voice for Canadian doctors who want to strengthen and improve Canada’s universal publicly-funded health care system in a way that benefits all Canadians.

MUNDELEIN, IL–(Marketwire – August 20, 2010) –  Medline Industries, Inc., the company that produced the original Pink Glove Dance, is looking for breast cancer survivors in the New York City and surrounding areas who want to be part of the next Pink Glove Dance video. The original video has become an internet sensation, generating more than 11 million views on YouTube since its release last November. The video features healthcare workers at Providence St. Vincent Medical Center in Portland, Ore. dancing while wearing pink gloves. Medline, based in Mundelein, Ill., is the largest privately held manufacturer and distributor of healthcare supplies in the country.

When and where will it be?
Filming will take place Saturday, August 28 at 10:00 a.m. at The Broadway Plaza in Times Square between 42nd and 43rd streets.

What are the qualifications to participate?
Participants need to be breast cancer survivors and willing to dance wearing pink gloves. No special dancing skills required. A choreographer will be there to teach simple routines.

How long will it take?
Approximately two hours.

How do I sign up?
Details of the video shoot and registration can be found online at www.pinkglovedance.com.
Although participants can just show up on the day of the event, participants are encouraged to register online. 

Why is this video being made?
The first video was created to help spread the word about breast cancer awareness and the importance of the healthcare worker who takes care of breast cancer patients. It was so successful and generated so much positive attention that hospitals around the country inquired about participating in the next video. So the idea of a sequel was developed that not only included hospital workers but breast cancer survivors too. 

Why pink exam gloves?
As a way to extend Medline’s breast cancer awareness campaign, the company developed a pink glove called Generation Pink™. Gloves are also the first point of contact between the healthcare worker and the patient. And, the fact the glove is pink, Medline hoped would get people talking about breast cancer. When the gloves were launched in October, Medline committed to donating $1 of every case purchased to the National Breast Cancer Foundation to fund mammograms for individuals who cannot afford them. In the past five years, Medline has donated almost $500,000 to the National Breast Cancer Foundation. 

ALEXANDRIA, VA–(Marketwire – August 20, 2010) – All people with type 1 diabetes, and some with type 2, need to inject or pump insulin into their bodies to survive. Figuring out how much insulin is necessary requires frequent monitoring and can be difficult, even risky. According to Diabetes Forecast, the consumer magazine of the American Diabetes Association, one of the most hopeful trends in diabetes research is the quest to develop an artificial pancreas, a device that could make the lives of people with diabetes safer, healthier and easier — possibly within the next few years.

Despite its name, the artificial pancreas would not replace the entire biological organ. Instead, its goal is to mimic the pancreatic beta cells, which are destroyed by a malfunctioning immune system in type 1 diabetes or have stopped producing adequate insulin supply in type 2 diabetes. The artificial pancreas would consist of three components; the first two, an insulin pump and a continuous glucose monitor (CGM), are already used by many people with diabetes. It’s the third piece that acts like a glue between the two systems: an algorithm that will turn data from the CGM into instructions for the insulin pump. “Closing the loop” with an algorithm may allow for an automated system of insulin dosing, allowing the person wearing the device to spend less time on daily diabetes management.

So if we already have insulin pumps and CGMs and we can do some math, why isn’t the artificial pancreas already in place? The main reason is the math itself — and its ability to contribute to safety. While some versions of the algorithm are being developed based on decades of diabetes research and even account for the imperfections of mechanical systems, like delays in CGM measurements or insulin delivery, the line between the ideal blood glucose range and a dangerously low level is very narrow. In fact, Aaron Kowalski, PhD, who oversees the Artificial Pancreas Project at the Juvenile Diabetes Research Foundation, tells Diabetes Forecast that the ideal target for glucose levels is “right next to hypoglycemia, so there’s very little buffer.”

As the artificial pancreas concept evolves, it has taken research into new directions, including shut-off mechanisms for insulin pumps when glucose levels drop too low, pumps that deliver a second hormone in addition to insulin that would raise blood glucose, faster-acting insulins that could make the automated artificial pancreas work more effectively, and, of course, several different algorithms with different capabilities based on an individual’s routine. Getting an artificial pancreas approved for market in the United States is going to take a lot of research — but scientists are closer than they’ve ever been before. 

The artificial pancreas would not be a cure for diabetes. But it has tremendous potential to improve and save lives. And, perhaps, the best part? “An artificial pancreas is there all the time,” says Boris Kovatchev, PhD, who developed one of the algorithms for a U.S. study. “It can make decisions while a person sleeps.” In a not too distant future, people with diabetes may finally be able to rest easy.

The September issue of Diabetes Forecast also reports on how health care reform will affect people with diabetes and their families, including what to expect, and when. By the time the new law has fully taken effect, diabetes should no longer keep people from getting and keeping adequate health insurance coverage.

This issue also offers:

• Eyes on the Prize: Prevention is crucial in combating retinopathy
• Diabetes and Dementia: Does type 2 care also bolster brain function?
• Pump Up the Volume: How to eat more but lose weight

Diabetes Forecast has been America’s leading diabetes magazine for more than 60 years, offering the latest news on diabetes research and treatment to provide information, inspiration, and support to people with diabetes. 

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, its mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

id=”nav_links”>

NEW YORK, NY–(Marketwire – August 20, 2010) –  The cost-savings associated with early disease detection and clinicians’ demand for better, more accurate diagnostic tools are key drivers for a predicted 5.8% yearly increase in the market for molecular imaging devices. According to a new report by healthcare market research publisher Kalorama Information, this market is expected to reach $6.6 billion by 2014.

Differing from traditional diagnostic tools, molecular imaging devices use biomarkers, which produce finer images that display molecular changes, allowing physicians to pinpoint diseases. Devices include nuclear medicine based PET, which renders metabolic information, and SPECT, which produces anatomical images. These devices are well known for their ability to detect the molecular basis of diseases, including neurological and cardiovascular based diseases. In tumors, they detect chemical signatures that provide an early warning. In addition, advances in these devices have recently helped to identify vulnerable plaque in at-risk cardiac patients. Kalorama notes that combining new molecular contrast agents with traditional diagnostic tools, such us Ultrasound, MRI and CT has enabled physicians to capture specific molecular pathways to track the progress of treatment. 

While rapid advances in molecular imaging devices are pushing growth, physicians are even quicker to demand better products with:

• minimal invasiveness,
• rapid imaging processing time,
• low imaging cost,
• low radiation dose, and
• optimal resolution and contrast.

“Meeting the growing demand for a better molecular imaging device is a big driver for companies seeking to break into this market,” says Bruce Carlson, publisher of Kalorama Information. “The market could even grow further if physicians’ demands are met and we see a rise in patient confidence, as this could translate into more individuals opting in for these services.”

The adoption of molecular imaging equipment is not exclusive to physicians, according to Kalorama. Pharmaceutical and biotechnology companies are also utilizing molecular imaging equipment, as it allows them to test drug candidates in vivo for mechanisms, disposition and efficacy. The big players, such as Siemens, GE Healthcare, Phillips, and Toshiba are teaming up with contrast media companies to develop the next generation of molecular imaging equipment.

Kalorama Information’s report, “Molecular Imaging Markets (Market Intelligence Analysis of Market Opportunities in Molecular Imaging),” contains more information on market forecasts, company profiles, and trends in the molecular imaging market. The report is available at:
http://www.kaloramainformation.com/redirect.asp?progid=79480&productid=2613825.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).

CLIFTON, NJ–(Marketwire – August 20, 2010) – Electronic Control Security, Inc. (OTCBB: EKCS) (ECSI), a global leader in perimeter security systems, today announced receipt of orders totaling $1.1 million for security upgrades at several U.S. Air Force bases and nuclear power stations to meet updated force protection and NRC requirements. In addition, proposals have been submitted for other U.S. Air Force base and nuclear power station upgrades scheduled for fiscal 2011 and 2012.

“These security upgrades have been in the planning stage since 2008 following the terror attacks against our domestic assets in 2001. All branches of government including the nuclear facilities are upgrading and hardening our facilities at an accelerated pace. The NRC has always been one step ahead of potential terrorist threats, and the Department of Defense has increased its efforts in hardening its facilities as well,” commented Arthur Barchenko, President and CEO of ECSI. “Our business is about assisting in the development of security solutions to prevent infiltration of high-value assets and to guard against potential terrorist penetration. We are very proud to be part of this on-going security and anti-terrorism process to help protect the nation’s sensitive and high-visibility sites.” 

These security upgrades include the design and installation of multi-layer security systems including ECSI’s Infrared Perimeter Intrusion Detection (IPID®) system, Fiber Optic Intelligence Detection System (FOIDS®), Intelligent Video Motion Detection (IVMD®) and infrared pan-tilt-zoom camera technology.

About ECSI
ECSI is a global leader in perimeter security and a quality provider to the Department of Defense, Department of Energy, nuclear power stations, and other large commercial-industrial complexes. The Company designs, manufactures and markets physical electronic security systems for high-profile, high-threat environments utilizing risk assessment and analysis to determine and address the security needs of its customers. Teaming agreements with major system integrators enable ECSI to support the installation and aftermarket of its products in the U.S. and overseas. ECSI is located at 790 Bloomfield Avenue, Bldg. C-1, Clifton, NJ 07012. Tel: 973-574-8555; Fax: 973-574-8562. For more information on ECSI and its customers, please visit http://www.ecsiinternational.com.

ECSI INTERNATIONAL, INC. SAFE HARBOR STATEMENT: This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry and reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to changes in economic conditions generally and in our industry specifically, changes in security technology, receipt and timing of collections from purchase orders, legislative or regulatory changes that affect us, the availability of working capital, changes in costs and the availability of goods and services, the introduction of competing products, changes in our operating strategy or development plans, sufficiency of cash reserves and the risks and uncertainties discussed under the heading “RISK FACTORS” in Item 1 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2009 and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

JOHANNESBURG, SOUTH AFRICA–(Marketwire – August 20, 2010) – www.wallstreetequityresearch.com gives shareholders valuable insight on REIT – healthcare facilities stocks Nationwide Health Properties Inc. (NYSE: NHP) and HCP Inc. (NYSE: HCP). Sign up today at www.wallstreetequityresearch.com to receive free research reports on these equities.

Investors in the REIT healthcare facility sector are hoping that an aging population of baby boomers and recent healthcare reform will translate to solid bottom lines for companies in the sector. Recent increases in occupancy at senior care facilities are reflective of a population drifting into old age.

www.wallstreetequityresearch.com is a specialized website where investors can have specific access to free reports REIT – healthcare facilities industry; traders looking for analyst opinions on Nationwide Health Properties Inc., HCP Inc. and other companies in this industry are welcomed to sign up for a free one year membership at http://www.wallstreetequityresearch.com/.

While interest expenses have put a damper on some companies’ earnings, the sector remains positive about the future as the population continues to age and the number of senior care facilities remains comparatively low. Companies are looking to partnerships and mergers to acquire more real estate, including medical office buildings and nursing care projects.

The increased buying activity, especially in medical office buildings, is due in part to the security of the investment. Generally speaking, medical office buildings provide positive returns over long periods of time. This coupled with the potential influx of customers has made medical office buildings attractive to many REIT healthcare companies. Visit us at http://www.wallstreetequityresearch.com/ to understand the catalysts and forces driving or affecting the REIT – healthcare facilities industry in today’s economic environment.

Early this month, Nationwide Health Properties Inc. posted its financial results with revenue surging 13% whilst HCP Inc. saw its revenue increase to $303 million. Traders can have complimentary access to today’s complete research reports on HCP Inc. and Nationwide Health Properties Inc. by signing up at http://wallstreetequityresearch.com/August202010HCPInc.(HCP)200810.php or http://wallstreetequityresearch.com/August202010NationwideHealthPropertiesInc.(NHP)200810.php. 

About Wall Street Equity Research: 
Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

SUN VALLEY, CA–(Marketwire – August 20, 2010) –  XTend Medical Corporation (PINKSHEETS: XMDC), a company that specializes in delivering life-changing medical technology to healthcare organizations globally, received confirmation that the Delaware Chancery Court has scheduled a mediation of the lawsuit that XTend commenced against U&I Bio-Tech Korea, U&I Bio-Tech California, Mr. Sam Lee, and Mr. Eric Shin. Through the litigation, XTend seeks to compel the defendants to perform their obligations under an Asset Purchase Agreement that the parties signed last December, including assigning all of the intellectual property associated with the BioHarp technology to XTend. The mediation proceeding is scheduled for September 30, 2010 at 9:30 am ET before the Honorable Sam Glasscock, III, Master in Chancery.

Mr. Paul D. Lisenby, the CEO of XTend, stated, “XTend Medical has secured a date from the Delaware Chancery Court for mediation between XTend and Sam Lee and the other defendants. It is our intention to present the facts of this case to Master Glasscock and to rely on his wisdom and expertise in complex business matters to assist the parties in resolving the case. The delays and disruption that the defendants have imposed on the company and its shareholders will hopefully finally come to an end through the mediation process. XTend feels very confident in the merits of its case against the defendants. Nevertheless, we look forward to putting this dispute behind us and moving forward with the development of the BioHarp.”

About XTend Medical

XTend Medical Corporation is a company that specializes in the sale, manufacturing, and distribution of the latest in medical devices and telemedicine solutions for the healthcare industry. The company is dedicated to insuring that the products and services that it offers to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. For further information, please contact the company at [email protected] or visit its website at www.bioharpunius.com.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions, and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

CHICAGO, IL–(Marketwire – August 19, 2010) –  The National Council of State Boards of Nursing (NCSBN^®)(www.ncsbn.org) recognized its dedicated and exceptional membership and guests at its annual awards ceremony on Thursday, Aug. 12, 2010. This ceremony was part of the NCSBN Annual Meeting and Delegate Assembly held in Portland, Ore., Aug. 11 -13, 2010.

Specific award recipients include:
Ann L. O’Sullivan, PhD, MSN, CRNP, CPNP, FAAN, board president, Pennsylvania State Board of Nursing, received the Meritorious Service Award, which is presented to a board or staff member of a member board for positive impact and significant contributions to the purposes of NCSBN.

Cathy Giessel, MS, RN, ANP, FAANP, recent past board chair, Alaska Board of Nursing, received the Exceptional Leadership Award, which is bestowed to an individual who has served as president of a member board and has made significant contributions to NCSBN in that role.

Sue Tedford, MNSc, RN, CNS, APN, board staff, Arkansas State Board of Nursing, and Valerie Smith, MS, RN, FRE, board staff, Arizona State Board of Nursing, each received the Exceptional Contribution Award, which is given for significant contribution by a board of nursing staff member who does not serve as an executive officer or a board member who is not the current board president.

The Texas Board of Nursing was awarded the Regulatory Achievement Award that recognizes the member board that has made an identifiable, significant contribution to the purpose of NCSBN in promoting public policy related to the safe and effective practice of nursing in the interest of public welfare.

In addition, service awards were given to the following executive officers of boards of nursing:

Five Years
Toaga Seumalo, MS, RN, executive secretary, American Samoa Health Services
Charlotte Beason, EdD, RN, NEA, executive director, Kentucky Board of Nursing
Rula Harb, MS, RN, executive director, Massachusetts Board of Registration in Nursing
Betsy Houchen, JD, MS, RN, executive director, Ohio Board of Nursing

10 Years
Barbara Zittel, PhD, RN, executive secretary, New York State Board of Nursing
Claire Doody Glaviano, MN, RN, executive director, Louisiana State Board of Practical Nurse Examiners

15 Years
Joey Ridenour, MN, RN, FAAN, executive director, Arizona State Board of Nursing
Laura Skidmore Rhodes, MSN, RN, executive director, West Virginia Board of Examiners for Registered Professional Nurses
Kathy Thomas, MN, RN, executive director, Texas Board of Nursing

25 Years
Libby Lund, MSN, RN, executive director, Tennessee State Board of Nursing

The following boards of nursing are celebrating 100 years of nursing regulation in 2010:
South Carolina State Board of Nursing
Massachusetts Board of Registration in Nursing

The National Council of State Boards of Nursing (NCSBN) is a not-for-profit organization whose members include the boards of nursing in the 50 states, the District of Columbia and four U.S. territories — American Samoa, Guam, Northern Mariana Islands and the Virgin Islands. There are also seven associate members.

The statements and opinions expressed are those of NCSBN and not the individual member state or territorial boards of nursing.

Mission: NCSBN provides education, service and research through collaborative leadership to promote regulatory excellence for patient safety and public protection.

National Council of State Boards of Nursing, Inc.
111 E. Wacker Drive, Suite 2900
Chicago, IL 60601-4277

CHICAGO, IL–(Marketwire – August 19, 2010) –  The National Council of State Boards of Nursing (NCSBN^®)(www.ncsbn.org) elected new members to its Board of Directors during its 2010 Delegate Assembly. Those elected include:

President
Myra A. Broadway, JD, MS, RN, executive director, Maine State Board of Nursing, was previously vice president from 2008-2010 and Area IV director from 2003-2007. During her tenure, Broadway was the board liaison to the Disciplinary Resources, Finance, Examination and Commitment to Ongoing Regulatory Excellence Committees and the Member Board Leadership Development Task Force. She also served as a director-at-large from 2000-2002 when she was board liaison to Commitment to Excellence and Model Rules Subcommittee. Broadway holds a J.D. from Franklin Pierce Law Center, an M.S.B.A. from Boston University, Metropolitan College, an M.S. from the University of Colorado and a B.S. from Hunter College in New York. Broadway served in the United States Air Force Nurse Corps on both active duty and in the Reserves, retiring as a colonel in 1998.

Vice President
Shirley Brekken, MS, RN, executive director, Minnesota Board of Nursing, previously served as Area II Director from 1990-1992. She has served on 12 NCSBN committees/task forces as either chair or committee member. Brekken is a partner in several Minnesota efforts related to patient safety and advancing a “Just Culture” (Minnesota Alliance for Patient Safety); nursing excellence (Stratis Health Institute); nursing workforce (Minnesota Center for Nursing BOD, Minnesota Colleagues in Caring and Minnesota Health Education and Industry Partnership Steering Committees); technology (Governor’s e-Licensing Steering Committee); and nursing leadership (Minnesota Organization of Leaders in Nursing).

Treasurer
Randall Hudspeth, MS, APRN-CNS/NP, FRE, FAANP, board member, Idaho Board of Nursing, was reelected treasurer. He previously served as a director-at-large. Hudspeth is an inducted Fellow of the NCSBN Institute of Regulatory Excellence, and has served two terms as board chairman and two terms as vice chairman of the Idaho Board of Nursing during his seven-year tenure as the advanced practice registered nurse representative.

Directors-at-Large
Julio Santiago, MSN, RN, CCRN, has served as director-at-large since 2009 and was the board liaison to the Nursys® Committee. He is the chairperson of the Illinois Board of Nursing and the member representing clinical practice since March 2005. Since 1990, Santiago has had extensive experience in nursing, including critical care, behavioral health and in administrative positions.

Katherine Thomas, MS, RN, executive director, Texas Board of Nursing, was reelected as director-at-large, having served her first term from 2008-2010. She previously served as the NCSBN representative to the APRN Joint Dialogue Group. She was also on several NCSBN Advanced Nursing Practice committees, chairing the APRN Advisory Committee from 1995-2007.

NCSBN delegates also elected members of the Leadership Succession Committee (LSC):

Area II Member
Lisa Emrich, MSN, RN, manager, Practice, Education and Administration, Ohio Board of Nursing

Area III Member
Brenda McDougal, associate executive director — Operations, North Carolina Board of Nursing

Area IV Member
Sue Petula, PhD, MSN, RN, NEA-BC, nursing education advisor, Pennsylvania State Board of Nursing

Additionally, the NCSBN Board of Directors appointed Louise Bailey, MEd, RN, interim executive director, California Board of Registered Nursing, to serve as the Area I Member on the LSC.

The National Council of State Boards of Nursing (NCSBN) is a not-for-profit organization whose members include the boards of nursing in the 50 states, the District of Columbia and four U.S. territories — American Samoa, Guam, Northern Mariana Islands and the Virgin Islands. There are also seven associate members.

The statements and opinions expressed are those of NCSBN and not the individual member state or territorial boards of nursing.

Mission: NCSBN provides education, service and research through collaborative leadership to promote regulatory excellence for patient safety and public protection.

National Council of State Boards of Nursing, Inc.
111 E. Wacker Drive, Suite 2900
Chicago, IL 60601-4277

CHICAGO, IL–(Marketwire – August 19, 2010) –  The National Council of State Boards of Nursing (NCSBN^®) (www.ncsbn.org) inducted its fourth group of Fellows of the NCSBN Regulatory Excellence Institute on Aug. 12, 2010, during the NCSBN Annual Meeting and Delegate Assembly held in Portland, Ore. The Institute of Regulatory Excellence (IRE) began in 2004 with the purpose of providing boards of nursing with high quality regulatory education, expanding the body of knowledge related to regulation through research and scholarly work, developing the capacity of regulators to become expert leaders, and developing a network of regulators who collaborate to improve regulatory practices and outcomes.

The 2010 class of Fellows includes:

Susan K. Odom, PhD, RN Chair, Idaho Board of Nursing

William E. Spooner, Regulatory Supervisor Consultant, Florida Board of Nursing

The IRE is a series of educational conferences held annually with the following topics rotated on a four-year cycle: Public Protection/Role Development of Nursing Regulators, Discipline, Competency and Evaluation/Remediation Strategies, and Organizational Structure/Behavior.

The IRE Fellowship Program is a four-year comprehensive educational and professional development program designed for current regulators who want to enhance their knowledge of and leadership in nursing regulation. The program includes experiences in analyzing issues involving public policy and regulation, strategic planning, patient safety and communication. It also requires the application of evidence-based concepts in decision making and leadership.

Individuals who complete the Fellowship Program requirements are called a Fellow of the NCSBN Regulatory Excellence Institute (FRE) and are entitled to use the initials FRE after their name in recognition of their accomplishment.

The National Council of State Boards of Nursing (NCSBN) is a not-for-profit organization whose members include the boards of nursing in the 50 states, the District of Columbia and four U.S. territories — American Samoa, Guam, Northern Mariana Islands and the Virgin Islands. There are also seven associate members.

Mission: NCSBN provides education, service and research through collaborative leadership to promote regulatory excellence for patient safety and public protection.

The statements and opinions expressed are those of NCSBN and not the individual member state or territorial boards of nursing.

National Council of State Boards of Nursing, Inc.
111 E. Wacker Drive, Suite 2900
Chicago, IL 60601-4277

IRVING, TX–(Marketwire – August 19, 2010) –  WaveTwo, LLC and its Health IT 2015 division have been chosen by the North Texas Regional Extension Center (NTREC) to be an official agent to all Physicians in North Texas. As an official agent, WaveTwo will assist North Texas physicians in implementing electronic health records (EHR) and qualifying for incentive payments from the Centers for Medicare and Medicaid Services (CMS).

NTREC was recently awarded an $8.5 million grant from the Office of the National Coordinator for Health Information Technology (ONC) to assist primary care providers, in a 41 county North Texas region, to adopt and achieve Meaningful Use of electronic health records (EHR). NTREC is the region’s designated federal expert in Meaningful Use standards as promulgated by the Office of National Coordinator for Health Information Technology (ONC). WaveTwo is now NTREC’s official agent to these physicians.

WaveTwo services to physicians will include education, technical EHR assistance, guidance in meeting Meaningful Use criteria and obtaining CMS incentive payments. WaveTwo’s goal is to assist 1,498 physicians in reaching Meaningful Use by April 2012. Physicians who do so will then qualify for incentive payments up to $44,000 per eligible professional.

“We are very proud to be chosen to perform this important work for Physicians and NTREC,” said John Arnott Sr., Managing Partner for WaveTwo. “Our entire Health IT 2015 division’s focus — for the next two years — will be to lead each of the applicants to ‘meaningful use’ and qualify for all of the incentive funds available to them.”

About WaveTwo. WaveTwo is a leading Texas provider of professional services focused on solving business problems through technology and processes, with a strong focus on healthcare clients. Founded in 2002 , WaveTwo provides Business Intelligence, Enterprise Systems, Managed IT Services, and CIO On-Demand Services. Its Health IT 2015 division provides vendor-agnostic healthcare technology planning and implementation services. For more information, contact WaveTwo at 214-271-0033 or visit www.wavetwo.com and www.healthIT2015.com.

About North Texas Regional Extension Center. The North Texas Regional Extension Center (NTREC) was established as a program by the Dallas Fort Worth Hospital Council Education and Research Foundation (DFWHC-ERF) in April 2010. Its primary purpose is to promote the adoption and meaningful use of Electronic Health Records (EHR) in the practices of priority primary care providers.

Click here to see all recent news from this company

CHICAGO, IL–(Marketwire – August 19, 2010) –  Sullivan, Cotter and Associates, Inc., a healthcare compensation and human resource management consulting firm, is in the process of publishing the 2010 Survey of Manager and Executive Compensation in Hospitals and Health Systems now in its eighteenth edition. This year, 288 health systems and 906 hospitals participated in the survey, a respected industry resource. Participants submitted data for nearly 22,000 executives and managers between February and June 2010. SullivanCotter’s national healthcare survey provides not only cash compensation data for executive and management jobs in hospitals and health systems, but also data on pay practices, annual incentive plans, supplemental benefits, perquisites, nonqualified retirement plans, and much more. Modern Healthcare, the nation’s leading healthcare weekly magazine, released portions of Sullivan, Cotter and Associates survey in its annual issue on healthcare executive compensation this week. 

When comparing the data from 211 health systems and 642 hospitals that participated in both 2009 and 2010, base salaries increased on average 2.9% and 2.6%, respectively. These increases are consistent with the projected 2010 salary increase budgets, which were 3.2% for health systems and 2.8% for hospitals. 

“Salary increases continue to be moderate,” noted SullivanCotter Managing Principal Tom Pavlik. “We continue to see this moderation in the reported executive and manager projected salary increase budgets for next year; the preliminary data indicate budgets of 3.0% for health systems and 2.7% for hospitals. However, we did see around a 5.5% increase in total cash compensation levels.”

The 2010 Survey of Manager and Executive Compensation in Hospitals and Health Systems will be available for purchase in September. The cost to healthcare organizations agreeing to participate in next year’s survey is $950; for those not wishing to participate, the cost is $1,950. The survey is also available to non-healthcare organizations. To order a copy, please visit the Sullivan, Cotter and Associates website at www.sullivancotter.com or contact Mary Kowalczyk, survey manager, at 312/739-2000, toll-free at 888/739-7039, or email [email protected].

Sullivan, Cotter and Associates, Inc. specializes in the development and implementation of strategic total compensation and reward programs for the healthcare industry. Since 1992, SullivanCotter has worked closely with healthcare organization executives, boards, and compensation committees to devise innovative compensation solutions that attract and retain leadership talent while satisfying not-for-profit missions and regulatory requirements. A leader in independent consulting, benchmarking, trends, and analyses, SullivanCotter has developed the most widely recognized physician and executive compensation surveys in the United States. SullivanCotter has offices in Atlanta, Boston, Chicago, Dallas, Detroit, Minneapolis, New York City, Parsippany, San Francisco, Washington DC, and Westport. For more information, visit www.sullivancotter.com or call 888-739-7039.

Click here to see all recent news from this company

HOUSTON, TX–(Marketwire – August 19, 2010) –  Nothing is worse than needing a good night’s sleep, but waking in the middle of the night with leg pain and movement. Houston Chiropractor Dr. Karen Thomason of 1960 West Chiropractic Center notes that many patients suffer from Restless leg syndrome (RLS), the irresistible urge of an individual to move their legs.

Restless leg syndrome can begin at any age, but it is more common in older patients and women, who are more likely to develop this condition than men. The symptoms include cramping, tingling, aching and a “crawling” sensation in the legs, thighs and calves. RLS affects most people at night, and lying down and trying to relax activates the symptoms. As a result, sleep is affected and exhaustion often ensues.

While many turn to prescription medications, Dr. Thomason notes that chiropractic treatment can alleviate many of the unpleasant symptoms of RLS and allow patients to have an uninterrupted night’s sleep, which is essential for good health.

“The symptoms of RLS are very uncomfortable and difficult to withstand,” said Dr. Thomason. “We have helped many patients with treatments to release the tension in the legs and calves. Chiropractic sessions have been effective in alleviating pain naturally, without the use of drugs.”

RLS affects as many as 12 million Americans and Houston chiropractic care is available through 1960 West Chiropractic to enable individuals suffering from RLS, or many other physical conditions such as back pain, neck pain, headaches, leg numbness and many more physical ailments, to heal naturally.

About 1960 West Chiropractic Center
1960 West Chiropractic Center was founded by native Houstonian, Dr. Karen S. Thomason. The practice, specializing in Chiropractic Care, has proven results in realigning or resetting the body to proper balance. Chiropractic treatment has been effective for patients in recovery from job injuries, accidents, sports injuries and chronic pain. Services include Chiropractic care, massage therapy, X-Ray Services and onsite active rehabilitation. 1960 West Chiropractic is a member of the Texas Chiropractic Association and the American Chiropractic Association.

Click here to see all recent news from this company

WASHINGTON, DC–(Marketwire – August 19, 2010) –  The National Risk Retention Association will open its 22^nd annual conference October 5 with an all day session devoted to issues affecting healthcare Risk Retention Groups, Sanford “Sandy” Elsass, Conference Chairman and President/CEO of Uni-Ter Underwriting Management Corporation, announced. Gloria Everett, President/CEO of MedAmerica Mutual Risk Retention Group, is Chair of the Healthcare Pre-Conference.

“Two thirds of the 247 RRGs in business today provide liability insurance to healthcare organizations so the pre-conference program will cover issues important to this sector of the industry,” Elsass said.

NRRA is the national trade association that represents the interests of Risk Retention Groups — insurance companies authorized by the federal Liability Risk Retention Act of 1986 to operate nationally without additional regulation when licensed in a single state. RRGs generated more than $2.5 billion of premiums in 2009.

“The pre-conference will provide healthcare RRG CEOs, captive managers, and related professional services firms information essential to successful operations in today’s rapidly changing healthcare environment,” Everett said. The program will feature topics ranging from State reporting requirements and tax issues to how to compete in a soft market.

Program topics, expert speakers, and panelists include:

Historical Perspectives on the Importance and Impact of Expert Witnesses: Dr. William Luria, President, Lancet Indemnity RRG; Kirsten Ullman, Managing Partner Southeast Region, Lewis Brisbois Bisgaard & Smith, LLP.

Gauging the Results of Proactive Claims Portfolio Management: John Spinella, Spinella & Associates, Inc.

Insurance Claims Coverage Issues: Moderator, Kimberley Wynkoop, Ophthalmic Mutual Insurance Co. RRG; Panelists: Jeffrey Johnson, attorney, Primmer Piper Eggleston & Cramer; Myra Barsoum Stockett, Reminger Attorneys at Law.

Reinsurance Placement: Moderator, Ken Barrett, Besso Re, Ltd.; Panelists: Jo McCann, Beazley Furlonge, Ltd.; Paul Western, Amlin Underwriting, Ltd.

Can RRGs Compete with Commercial Carriers in a Soft Market: Robert Bates, Continuing Care RRG;Gloria Everett, President, MedAmerica Mutual RRG; Sanford “Sandy” Elsass, President, The Uni-Ter Group.

Medical Professional Liability Claims Reporting: Michael Stinson, Physician Insurers Association of America and Kimberley Wynkoop, Ophthalmic Mutual Insurance Co. RRG

Trends in Losses and Reserves — Hard Markets Follow Drops in Surplus: Moderator, Joseph Petrelli, President/CEO, Demotech, Inc.; Panelists: Kevin Bingham, Deloitte Consulting, LLP; Richard Lord, Milliman.

Investment Strategies for Long-Tail Liability Reserves: Moderator, Patrick Tuohy, Senior Vice President, Prime Advisors, Inc.; Panelists: Steven Lee, Managing Director, Logan Capital Management; Christopher Mertes, CFO, MedAmerica Mutual RRG.

The conference will be held at The Ritz Carlton Pentagon City Hotel, Washington, DC. Attendees can register online and the full Conference schedule is available on the web site, www.riskretention.org.

Click here to see all recent news from this company

KANSAS CITY, MO–(Marketwire – August 18, 2010) –  Xact Data Discovery (XDD) is excited to announce the completion of HIPAA certification in its national offices. The Health Insurance Portability and Accountability Act (HIPAA) of 1996 was enacted to ensure that individuals would be able to maintain their health insurance between jobs as well as to ensure the security and confidentiality of patient information/data.

Xact Data Discovery’s HIPAA certification process included development of new policies surrounding the handling of client information. As a Business Associate, XDD is compliant with the regulations in all areas of HIPAA and will conduct annual risk assessments as well as associate training to ensure that all electronic personal health information (EPHI) and personal health information (PHI) is protected. XDD’s Director of Human Resources, Katie Ervin will administer the program. Ervin has nearly 13 years experience working with HIPAA achieving certification as a Certified HIPAA Professional (CHP).

“While we have always protected all information we process for clients, this certification just takes it to a higher level,” said Robert Polus, President and CEO of XDD. “We take the extra steps above and beyond to be sure we are compliant. This allows us to work with those covered entities that must follow HIPAA such as hospitals, insurance carriers, and pharmacies to name a few.”

Xact Data Discovery is a national Data Discovery and Management company that provides streamlined Forensic, Electronic Discovery, Data Hosting, Data Management, Imaging/Coding and Paper Discovery Services to law firms, corporations and government agencies. At Xact Data Discovery, communication is everything — because clients need to know where their data is throughout the entire process, as well as understand the valuable information and knowledge they can attain from it.

Via a personable “human-interface” approach, Xact Data Discovery streamlines the complex communication process between people, technology and data by orchestrating proactive, clear, consistent and relentless communication throughout all project phases. Xact Data Discovery helps clients and their customers find, produce, use and understand information crucial to their organizations.

IRVINE, CA–(Marketwire – August 18, 2010) –  Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced the closing of its previously announced underwritten public offering of 26,750,000 shares of its common stock, as well as the closing of the underwriters’ over-allotment option to purchase an additional 4,012,500 shares of common stock. The net proceeds of the offering, after giving effect to the issuance and sale of all 30,762,500 shares of common stock at a price to the public of $7.75 per share, were approximately $224.8 million after deducting the underwriting discount and estimated offering expenses. Sun intends to use the net proceeds from the offering to repay a portion of the outstanding term loans under its existing credit facility.

Richard K. Matros, Sun’s chairman and chief executive officer, commented, “We are pleased with the response to the equity offering, which provides us the ability to pay down a significant portion of our indebtedness. Following the success of this offering, we are looking forward to completion of the proposed separation of our operating businesses and our real estate assets.”

This press release does not constitute an offer to sell or a solicitation of any offer to buy the shares of Sun’s common stock described herein, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

The prospectus supplement and the related prospectus relating to the offering may be obtained by written request to Jefferies & Company, Inc., Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 12th Floor, New York, NY 10022; by telephone at (877) 547-6340; or by e-mail at [email protected]; or Credit Suisse Securities (USA) LLC, Attention: Credit Suisse Prospectus Department, One Madison Avenue, New York, NY 10010 or by telephone at (800) 221-1037.

About Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc.’s (NASDAQ: SUNH) subsidiaries provide nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Sun’s core business is providing, through its subsidiaries, inpatient services, primarily through 166 skilled nursing centers, 16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers. On a consolidated basis, Sun has annual revenues of $1.9 billion and approximately 30,000 employees in 46 states. At June 30, 2010, SunBridge centers had 23,209 licensed beds located in 25 states, of which 22,427 were available for occupancy. Sun also provides rehabilitation therapy services to affiliated and non-affiliated centers through its SunDance subsidiary, medical staffing services through its CareerStaff Unlimited subsidiary and hospice services through its SolAmor subsidiary. 

Forward-Looking Statements

Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “hope,” “intend,” “may” and similar expressions. Factors that could cause actual results to differ are identified in the public filings made by the Company with the Securities and Exchange Commission and include our ability to complete the separation of our operating businesses and our real estate assets. More information on factors that could affect our business and financial results are included in our public filings made with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun’s web site, www.sunh.com. The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. We caution investors that any forward-looking statements made by Sun are not guarantees of future performance. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

ALEXANDRIA, VA–(Marketwire – August 18, 2010) –  Alpha Kappa Alpha Sorority (AKA) is joining forces with the American Diabetes Association‘s African American Initiatives — known as Live EMPOWERED — to stop diabetes in the African American Community. The collaboration is driven by the reality that African Americans are greatly affected by diabetes; they are 1.8 times more likely to have type 2 diabetes than non-Latino whites. 

To combat this epidemic, beginning in the spring of 2011, the AKAs will designate 10 undergraduate chapters at Historically Black Colleges and Universities to lead diabetes workshops and activities. Through this initiative, the Sorority hopes to spread the message about how to prevent diabetes and provide tools to assist those with diabetes to live a productive life with this disease. In announcing the partnership, AKA’s newly installed international president Attorney Carolyn House Stewart stated, “Alpha Kappa Alpha Sorority’s goal is to help our community recognize the risks of this disease, its many complications and treatment options. We will host forums that will heighten awareness and offer prevention strategies to help eliminate this deadly disease that shortens lives and impacts the quality of life of many African Americans of all ages.” 

AKA and the American Diabetes Association share common priorities and interests in reaching African Americans, students and other key constituents with important awareness messaging relating to diabetes, including risk factors, prevention strategies, warning signs, and management of the disease.

Both organizations have unique competencies to address these issues and believe that there will be a greater opportunity to promote mutual goals through multiple communications channels. This collaboration is especially significant, because African-American women are at a greater risk for the number one complication of diabetes: heart disease.

“By getting this powerful group of women to join us in our movement to Stop Diabetes, we have the potential to change many lives and communities,” said Earnestine Walker, Director of Community Outreach at the American Diabetes Association.

About Alpha Kappa Alpha Sorority:
Founded in 1908, on the campus of Howard University in Washington, DC, Alpha Kappa Alpha (AKA) is the oldest Greek-lettered organization established by African-American college-educated women. AKA’s membership is comprised of 260,000 distinguished women in graduate and undergraduate chapters in the United States and abroad who boast excellent academic records, proven leadership skills, and who are involved in the global community through advocacy and service. Attorney Carolyn House Stewart is the 28th International President and will serve from 2010 – 2014. Her administration’s theme is “Global Leadership Through Timeless Service.”

About the American Diabetes Association:
The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Click here to see all recent news from this company

CHICAGO, IL–(Marketwire – August 18, 2010) –  The National Council of State Boards of Nursing (NCSBN^® )(www.ncsbn.org) sets an ambitious research agenda designed to advance the science of nursing regulation. NCSBN recently added to its body of research with the publication of four new briefs titled, Report of Findings from the 2009 TUNING Analysis: A Comparison of U.S. and International Nursing Educational Competencies; Report of Findings from the 2009 Job Analysis of Nurse Aides Employed in Nursing Homes/Long-term Care, Hospitals/Acute Care and Community/Home Health Care Settings; Report of Findings from the Comparison of Entry-level Registered Nurses in the U.S. and Ontario, Canada; and Report of Findings from the Comparison of Entry-level Registered Nurses in the U.S. and British Columbia, Canada.

Report of Findings from the 2009 TUNING Analysis: A Comparison of U.S. and International Nursing Educational Competencies is an account of a new initiative that seeks to understand the role of nurses and nursing education from an international perspective. The goal of this study was to evaluate the consistency of nursing educational competencies globally.

Report of Findings from the 2009 Job Analysis of Nurse Aides Employed in Nursing Homes/Long-term Care, Hospitals/Acute Care and Community/Home Health Care Settings reports the importance ratings for activities performed by certified entry-level nurse aides/nursing assistants (NAs) employed in various health care settings. The findings from this study are used to evaluate the validity of the test plan, content outline and examination questions for the nurse aide certification examination.

Report of Findings from the Comparison of Entry-level Registered Nurses in the U.S. and Ontario, Canada compares entry-level nursing activities of U.S. registered nurses with a cohort from Ontario, Canada. The College of Nurses of Ontario (CNO) collaborated with NCSBN on this initiative.

Report of Findings from the Comparison of Entry-level Registered Nurses in the U.S. and British Columbia, Canada compares entry-level nursing activities of U.S. registered nurses with a cohort from British Columbia, Canada. The College of Registered Nurses of British Columbia (CRNBC) collaborated with NCSBN on this initiative.

NCSBN offers 48 volumes of research that include practice analyses and national surveys of the profession, covering topics such as nursing education and professional issues. Previously only available for purchase through NCSBN, these research briefs are now downloadable free of charge by visiting www.ncsbn.org.

The National Council of State Boards of Nursing (NCSBN^®) is a not-for-profit organization whose members include the boards of nursing in the 50 states, the District of Columbia and four U.S. territories — American Samoa, Guam, Northern Mariana Islands and the Virgin Islands. There are also seven associate members.

Mission: NCSBN provides education, service and research through collaborative leadership to promote regulatory excellence for patient safety and public protection.

The statements and opinions expressed are those of NCSBN and not the individual member state or territorial boards of nursing.

National Council of State Boards of Nursing, Inc.
111 E. Wacker Drive, Suite 2900
Chicago, IL 60601-4277

CHICAGO, IL–(Marketwire – August 18, 2010) –  The National Council of State Boards of Nursing (NCSBN^® )(www.ncsbn.org) is raising the passing standard for the National Nurse Aide Assessment Program (NNAAP^®) Written and Oral Examination. The new passing standard is 1.57 logits, 0.24 logits higher than the current standard of 1.33 logits. The new passing standard will take effect on Jan. 1, 2011.

The updated passing standard was set during a standard-setting workshop, held April 21-22, 2010. A panel of 10 registered nurses (RNs) representing a variety of practice settings across the country volunteered as subject matter experts (SMEs) for the workshop. After consideration of all available information, the SMEs determined that safe and effective certified entry-level nurse aide/nursing assistant (NA) work requires a greater level of knowledge, skills and abilities than was required in 2006, when the current standard was implemented. The passing standard was increased in response to changes in U.S. health care delivery that have resulted in a wider range of knowledge required by certified entry-level NAs to perform their authorized duties. The SMEs used multiple sources of information, including the results of a criterion-reference standard-setting workshop, to guide their evaluation and discussion regarding the change in passing standard.

In accordance with contractual agreements with client jurisdictions, NCSBN is responsible for evaluating the passing standard of NNAAP every five years to protect the public by assuring minimal competence for entry-level certified NAs. NCSBN coordinates the passing standard analysis with the five-year cycle of test plan evaluation. This five-year cycle was developed to keep the test plan and passing standard current and reflective of entry-level work expectations for certified NAs. The 2011 NNAAP^® Examination Test Plan/Test Specifications Report is available to download free of charge at www.ncsbn.org/2011_NNAAP_Test_Plan-Test_Specifications_Report_links.pdf.

The National Council of State Boards of Nursing (NCSBN^®) is a not-for-profit organization whose members include the boards of nursing in the 50 states, the District of Columbia and four U.S. territories — American Samoa, Guam, Northern Mariana Islands and the Virgin Islands. There are also seven associate members.

Mission: NCSBN provides education, service and research through collaborative leadership to promote regulatory excellence for patient safety and public protection.

The statements and opinions expressed are those of NCSBN and not the individual member state or territorial boards of nursing.

National Council of State Boards of Nursing, Inc.
111 E. Wacker Drive, Suite 2900
Chicago, IL 60601-4277

CHICAGO, IL–(Marketwire – August 18, 2010) – With health insurance all over the news and a main topic in politics, it’s more important than ever to get the right coverage for the future. Health insurance can be a complicated service for those that are not well versed in the industry. It can be difficult for individuals and businesses to find the right plan. In many cases consumers and companies either have a plan that does not fit their needs or may be paying too much. It is always a good idea to research and talk with professionals about their health insurance coverage in order to make sure they are getting the coverage they need.

ChicagoGroupHealthInsurance.net connects individuals and consumers with a group health insurance agent, where they can speak with an insurance agent about their prospective plan. This can open up new possibilities for Illinois residents seeking health insurance.

For small business owners group health insurance has various cost and tax incentives for both them and their employees. These benefits can vary depending on the individual and business owner’s situation. Connecting with a professional can help them assess their situation.

ChicagoGroupInsurance.net offers a free consultation with a group health insurance representative which can be taken advantage of at their company website www.ChicagoGroupInsurance.net/

Click here to see all recent news from this company